Asia Pacific Diabetic Pen Market is Expected to grow at a CAGR of ~7 % by 2023

Pune, India, June 15, 2017 /MRFR Press Release/- Market research future published a half cooked research report on Asia Pacific Diabetic Pen market. The Asia Pacific Diabetic Pen market is expected to grow over the CAGR of around 7% during the period 2023 

Diabetes is a lifestyle disease caused due to rise in blood glucose level due to less or no insulin production in the body. Diabetes is divided into two type, type 1 diabetes which is associated with no or very less insulin secretion by the body. Type 2 diabetes is the condition in which body resist to produce insulin and for this purpose diabetes pens are used. Diabetic Pen is the improved version of the syringes. They are the better and convenient way for administration of insulin into the body.Asia Pacific diabetic pen market is expecting a considerable growth in upcoming future. The major driving factor for the growth of diabetic pen market is increasing diabetic population. Asia Pacific most populated region which increases the possibility of the increasing the diabetic population. Furthermore, due to increasing awareness about the management of the diabetes in developing countries, there is an increase in the demand for various diagnostic and treatment devices for diabetes. Beside this technological advances has provided a better opportunities for the multinational and local manufacturing companies.

Figure 1:-

Market Synopsis

of Diabetes Pen Market by Devices, 2016 (%):

Asia Pacific Diabetes Pen market has been segmented on the basis of-

• By product used which includes Insulin Pens and Insulin Pen Needle


• On the basis of usage which includes reusable pens and disposable pens


• On the basis of distribution channel which include Hospital Pharmacy, Retail Pharmacy, Online Sales, and Diabetes Clinics


• On the basis of End user they are Hospital, clinics and Others


• 
  On the basis of region they are India, Japan, China, Australia, Republic of Korea and Rest of Asia Pacific 

Insulin Pens are the mostly used devices for the injection of insulin into the body over insulin pen needles. They covers nearly 70% of total market. Due to continence, easy to handle and dose accuracy are the major plus points of using insulin pens.On geographical basis Asia Pacific is segmented into India, Japan, China, Australia, Republic of Korea and Rest of Asia Pacific. China holds the highest share which is followed by India and then Japan. Due to huge population in India and China this region provides a very good opportunities to the manufacturer. Increasing diabetic population in this countries is the major factor for the development of the market. Asia pacific diabetic pen market is expected to grow at a CAGR of ~ 7% during forecast period of 2017- 2023.The major companies in the diabetic pen market are Roche Diagnostics AG (Switzerland), AstraZeneca plc. (UK), Johnson & Johnson (US), Abbott Laboratories (US), Biocon Ltd., Dexcom, Inc. (U.S.),  Becton-Dickinson, Owen Mumford Ltd. (UK), Jiangsu Delfu Co., Novo Nordisk A/S (Denmark), Ypsomed AG (Switzerland), Medtronic plc (US), and Tandem Diabetes Care (US), Inc., Eli Lilly and Company (US), Sanofi  S. A. (France), and Wockhardt Ltd (India).

Access Complete Report at https://www.marketresearchfuture.com/reports/asia-pacific-diabetes-pen-market-637 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our cooked research report (CRR), half-cooked research reports (HCRR), raw research reports (3R), continuous-feed research (CFR), and market research & consulting services.

MRFR team have supreme objective to provide optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users and market players for global, regional and country level market segments, enables our clients to see more, know more and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with industry experts and does industrial visits for its research analyst members.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com